241 related articles for article (PubMed ID: 11013901)
1. Additional issues raised on blood returns and ports.
Morris DJ
Oncol Nurs Forum; 2000 Sep; 27(8):1202-3. PubMed ID: 11013901
[No Abstract] [Full Text] [Related]
2. Reader looking for guidelines/policies on continuous infusion vesicants for assessments.
Parran L
Oncol Nurs Forum; 2000 Sep; 27(8):1201-2. PubMed ID: 11013900
[No Abstract] [Full Text] [Related]
3. Chemotherapy extravasation from implanted ports.
Schulmeister L; Camp-Sorrell D
Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
[TBL] [Abstract][Full Text] [Related]
4. [Update on implantable chambers].
Nahum S
Soins Gerontol; 2006; (61):17-20. PubMed ID: 17063848
[No Abstract] [Full Text] [Related]
5. The case of the painful port.
Eisenberg S
ONS Connect; 2012 Jan; 27(1):19. PubMed ID: 22355897
[No Abstract] [Full Text] [Related]
6. Vesicant extravasation from an implanted venous access port.
Wickham R
Oncology (Williston Park); 2009 Apr; 23(4 Suppl Nurse Ed):34-8. PubMed ID: 19856596
[TBL] [Abstract][Full Text] [Related]
7. Readers share comments and questions about extravasation management.
Schulmeister L
Oncol Nurs Forum; 2007 Mar; 34(2):275; author reply 276-80. PubMed ID: 17573287
[No Abstract] [Full Text] [Related]
8. Venous access ports: frequency and management of complications in oncology patients.
Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
[TBL] [Abstract][Full Text] [Related]
9. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
Sauerland C; Engelking C; Wickham R; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
[TBL] [Abstract][Full Text] [Related]
10. [The hospital nurse and chemotherapy].
Proust A
Soins; 2008 Mar; (723):48-50. PubMed ID: 18380314
[No Abstract] [Full Text] [Related]
11. Developing extravasation protocols and monitoring outcomes.
Camp-Sorrell D
J Intraven Nurs; 1998; 21(4):232-9. PubMed ID: 9866539
[TBL] [Abstract][Full Text] [Related]
12. Accessing implanted ports: still a source of controversy.
Eisenberg S
Clin J Oncol Nurs; 2011 Jun; 15(3):324-6. PubMed ID: 21624868
[TBL] [Abstract][Full Text] [Related]
13. Current controversies in chemotherapy administration.
San Angel F
J Intraven Nurs; 1995; 18(1):16-23. PubMed ID: 7707167
[TBL] [Abstract][Full Text] [Related]
14. [Administration of cytostatic agents: how to prevent extravasation].
Glaus A
Rev Infirm; 1995 Feb; (3):49-56. PubMed ID: 7652390
[No Abstract] [Full Text] [Related]
15. IV vesicants: how to avoid extravasation.
Wood LS; Gullo SM
Am J Nurs; 1993 Apr; 93(4):42-6. PubMed ID: 8480802
[No Abstract] [Full Text] [Related]
16. Extravasation of infusate via implanted ports: two case studies.
Viale PH; Yamamoto DS; Geyton JE
Clin J Oncol Nurs; 1999 Oct; 3(4):145-51. PubMed ID: 10703320
[TBL] [Abstract][Full Text] [Related]
17. [Management of cases with complications].
Clément F
Soins; 1997 Oct; (619):31-2. PubMed ID: 9416209
[No Abstract] [Full Text] [Related]
18. Extravasations of oxaliplatin.
Kretzschmar A; Pink D; Thuss-Patience P; Dörken B; Reichert P; Eckert R
J Clin Oncol; 2003 Nov; 21(21):4068-9. PubMed ID: 14581435
[No Abstract] [Full Text] [Related]
19. Extravasation. The dreaded complication.
Wetmore N
NITA; 1985; 8(1):47-9. PubMed ID: 3844096
[No Abstract] [Full Text] [Related]
20. Reducing the risks of infiltration and extravasation.
Rosenthal K
Nursing; 2007; 37 Suppl Med():4-8. PubMed ID: 18163033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
